Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleep Loss and Inflammation-Induced Depression (SHINE)
NCT02270619Phase 1Completed
- Sponsor
- University of California, Los Angeles
- Start
- Oct 2014
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in major depressive disorder (MDD), sponsored by University of California, Los Angeles. Started Oct 2014; status: completed.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02270619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02270619.